Diagnosing Minimal Hepatic Encephalopathy
NCT05433948 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2024-12-02
Summary
Our purpose is to
1. Examine the correlation between MDF in a resting EEG, recorded just before the CRT test, and the variance in reaction times indicated by the CRT index
2. At simultaneous CRT and EEG recording, examine whether a change in EEG is seen immediately before an extended reaction time occurs (defined by the 75th percentile). This will shed light on a direct pathophysiological association between what is measured with EEG and CRT.
3. Investigate whether cyclicity can be detected in the continuous reaction times and if so, whether amplitude and wavelength in this cyclic activity are correlated to EEG parameters.
4. Examine whether a response to standard HE treatment can be detected with EEG in patients who are thought to suffer from it. As well as if baseline outcome predict future hepatic encephalopathy.
5. With a view to further validating our findings, investigators want to correlate results from EEG and CRT with the most internationally widespread psychometric test, the Portosystemic Encephalopathy test (PSE), which necessitates the establishment of Danish normal values. A secondary purpose of this study is therefore
6. To establish Danish normal values for the PSE test and the Animal Naming test in Danes
Conditions
- Hepatic Encephalopathy
- Liver Cirrhosis
Interventions
- DIAGNOSTIC_TEST
-
Simultaneous EEG and CRT
EEG is recorded with 32 electrodes and commercial recording equipment.10 min EEG is recorded in idle mode with eyes closed prior to continuous EEG recording during the CRT examination, see below. The test is performed via a laptop using EKHO software. The software generates 150 sound stimuli of 90 dB, which the patient hears in sound-insulated headphones. Via a push button in the dominant hand, the patient must respond as quickly as possible as soon as sounds are perceived. PSE test: Duration 20 min. Includes 5 tasks: Digit-symbol Test, Number Connecting Test A, Number Connecting Test B, Serial Dotting Test and Line Tracing Test. Exits in 4 versions, which are used in repeated tests to avoid the learning effect. Scores range from -18 t0 6 and less -4 is abnormal.
Sponsors & Collaborators
-
Regionshospitalet Silkeborg
collaborator OTHER -
Herlev Hospital
collaborator OTHER -
Aalborg University Hospital
collaborator OTHER -
Esbjerg Hospital - University Hospital of Southern Denmark
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2026-12-01
- Completion
- 2031-12-01
Countries
- Denmark
Study Locations
More Related Trials
-
To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema
NCT04991259 ·Status: UNKNOWN ·Phase: NA
-
Prospective Cohort Study of Disease and Outcomes in Cirrhosis
NCT04422223 ·Status: UNKNOWN
-
Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study
NCT06619106 ·Status: RECRUITING
-
Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis
NCT05466669 ·Status: UNKNOWN
-
Cerebral Microdialysis in Patients With Fulminant Hepatic Failure
NCT00836420 ·Status: COMPLETED
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921 ·Status: RECRUITING
-
EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic Encephalopathy
NCT03732118 ·Status: UNKNOWN
-
Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement
NCT06814990 ·Status: RECRUITING ·Phase: NA
-
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)
NCT05140837 ·Status: UNKNOWN
-
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
NCT04807803 ·Status: COMPLETED ·Phase: NA
-
Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE
NCT04317222 ·Status: UNKNOWN ·Phase: NA
-
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
NCT06052176 ·Status: RECRUITING ·Phase: PHASE2
-
Liver Transplant Does it Affect the Brain
NCT04368052 ·Status: COMPLETED ·Phase: NA
-
Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
NCT05421351 ·Status: UNKNOWN
-
Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic
NCT03580577 ·Status: UNKNOWN
-
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
NCT03585257 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic Liver Tests in Liver Disease
NCT02782247 ·Status: COMPLETED
-
Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis
NCT02307409 ·Status: COMPLETED
-
HepQuant to Predict Hepatic Encephalopathy After TIPS
NCT04664621 ·Status: WITHDRAWN ·Phase: NA
-
Assessment of Hemostatic Profile in Liver Cirrhosis
NCT04265508 ·Status: COMPLETED
-
Renal Function Determination in Patients With Liver Cirrhosis
NCT02047240 ·Status: COMPLETED
-
Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic Patients
NCT04340999 ·Status: COMPLETED
-
Metobolomics in the Characterisation of HE
NCT06245473 ·Status: COMPLETED
-
Assessment of Coagulation Abnormalities in Acute on Chronic Liver Failure Patients Using Thromboelastography
NCT02757170 ·Status: UNKNOWN ·Phase: PHASE4